310 related articles for article (PubMed ID: 28820644)
41. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
42. A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population.
Wallace E; Hinds A; Campbell H; Mackay J; Cetnarskyj R; Porteous ME
Br J Cancer; 2004 Oct; 91(8):1575-9. PubMed ID: 15381929
[TBL] [Abstract][Full Text] [Related]
43. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations.
Kadouri L; Hubert A; Rotenberg Y; Hamburger T; Sagi M; Nechushtan C; Abeliovich D; Peretz T
J Med Genet; 2007 Jul; 44(7):467-71. PubMed ID: 17307836
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women.
Ozanne EM; Howe R; Mallinson D; Esserman L; Van't Veer LJ; Kaplan CP
J Genet Couns; 2019 Jun; 28(3):507-515. PubMed ID: 30663827
[TBL] [Abstract][Full Text] [Related]
45. Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.
Younes N; Zayed H
Gene; 2019 Feb; 684():154-164. PubMed ID: 30352249
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic criteria for testing for BRCA1 and BRCA2: the experience of the Department of Defense Familial Breast/Ovarian Cancer Research Project.
Fries MH; Holt C; Carpenter I; Carter CL; Daniels J; Flanagan J; Murphy K; Hailey BJ; Martin L; Hume R; Hudson G; Cadman M; Weatherly R; Nunes ME
Mil Med; 2002 Feb; 167(2):99-103. PubMed ID: 11873550
[TBL] [Abstract][Full Text] [Related]
47. Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women.
Ngene SO; Adedokun B; Adejumo P; Olopade O
J Genet Couns; 2018 Aug; 27(4):863-873. PubMed ID: 29260484
[TBL] [Abstract][Full Text] [Related]
48. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
49. Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers.
Kroiss R; Winkler V; Bikas D; Fleischmann E; Mainau C; Frommlet F; Muhr D; Fuerhauser C; Tea M; Bittner B; Kubista E; Oefner PJ; Bauer P; Wagner TM;
Hum Mutat; 2005 Dec; 26(6):583-9. PubMed ID: 16287141
[TBL] [Abstract][Full Text] [Related]
50. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.
Sutcliffe S; Pharoah PD; Easton DF; Ponder BA
Int J Cancer; 2000 Jul; 87(1):110-7. PubMed ID: 10861460
[TBL] [Abstract][Full Text] [Related]
51. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
52. Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.
Lanceley A; Eagle Z; Ogden G; Gessler S; Razvi K; Ledermann JA; Side L
Int J Gynecol Cancer; 2012 Feb; 22(2):254-9. PubMed ID: 22274317
[TBL] [Abstract][Full Text] [Related]
53. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
54. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
55. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
56. Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
Li J; Li B; Jiang Q; Zhang Y; Liu A; Wang H; Zhang J; Qin Q; Hong Z; Li BA
Gene; 2018 Nov; 677():211-227. PubMed ID: 30059751
[TBL] [Abstract][Full Text] [Related]
57. Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
Grindedal EM; Heramb C; Karsrud I; Ariansen SL; Mæhle L; Undlien DE; Norum J; Schlichting E
BMC Cancer; 2017 Jun; 17(1):438. PubMed ID: 28637432
[TBL] [Abstract][Full Text] [Related]
58. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
[TBL] [Abstract][Full Text] [Related]
59. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
[TBL] [Abstract][Full Text] [Related]
60. Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.
Rump A; Benet-Pages A; Schubert S; Kuhlmann JD; Janavičius R; Macháčková E; Foretová L; Kleibl Z; Lhota F; Zemankova P; Betcheva-Krajcir E; Mackenroth L; Hackmann K; Lehmann J; Nissen A; DiDonato N; Opitz R; Thiele H; Kast K; Wimberger P; Holinski-Feder E; Emmert S; Schröck E; Klink B
PLoS Genet; 2016 Aug; 12(8):e1006248. PubMed ID: 27504877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
